MedTech Week Magazine 2018 At a glance
Highlights from the 3rd Edition of the Award-Winning MedTech Week Magazine
Twitter accounts reached
#MedTechWeek used 3000+ times
I take this opportunity to sincerely thank all our members for their enormous efforts in making the role of medical technologies more widely known during MedTech Week 2018 last June.
Now in it's fourth year, MedTech Week brings out the best in the companies and national associations that represent our industry. Together, they have served up dozens of examples in unwavering ingenuity to illustrate the value of medtech.
Bringing Sound & Vision to the message
MedTech is all around us but often goes unseen – and undervalued
Keeping you running
MedTech Europe go the extra mile in Brussels
Virus or bacterium?
Knowing the cause of an illness helps accelerate recovery, avoids waste of resources and reduces antimicrobial resistance
Exploring the connection between sport, health and medtech
Race against time
The next French medtech Unicorns
Young companies rewarded for innovative new creations
Start-ups find inspiration in six-month accelerator program
Food for thought
Access to innovation was on the menu at ‘parliamentary breakfast’
Extraordinary stories, ordinary lives
Meet the patients for whom medtech is a way of life
Digital health will boost patient safety and tackle infection control
‘Dialysis at home: savings lives, preserving autonomy’
Dialysis can be essential to the wellbeing of people living with kidney failure.
‘Committed to protect our health from Roberto Bertollini, HFE honorary president’
‘Thinking smarter & working harder to deliver Value-Based Healthcare – Together’
Michelle Brennan, Chair of the Board of MedTech Europe and Company Group Chair, Johnson & Johnson Medical Devices Companies, Europe, Middle East & Africa (EMEA)
‘Artificial intelligence: The next revolution in healthcare?’
At the turn of the century, healthcare companies were at the zenith of an ‘innovate-manufacture-sell’ business model.
‘How digital technologies will reshape musculoskeletal healthcare’
Digital technologies provide an opportunity to move musculoskeletal care to the heart of value-based healthcare. MedTech Views spoke to Satschin Bansal of Zimmer Biomet about some of the innovations that will change the field.
‘Colorectal cancer: don’t delay diagnosis’
Colorectal cancer is the third most common cancer in the world and the second most common in Europe. The disease can be fatal but early diagnosis and intervention are improving outcomes for patients.
‘Diagnosing STIs: faster tests for chlamydia and gonorrhoea can help reduce the spread of disease’
Advances in diagnostic technologies give patients same-day test results for sexually transmitted infections (STIs) such as chlamydia and gonorrhoea.
‘Asthma is a struggle – imagine carrying a 50kg stone around all day’
For people living with severe asthma, daily tasks can be a real challenge.
‘Digital health is here – time to take the lead’
How do we prepare Europe for future technologies?
Timely cochlear implant surgery can significantly help deaf children’s speech, language, cognitive and socio-emotional behaviour.
Medical Technologies play key role in beating superbugs in a healthcare setting
Every year, more than 4.1 million Europeans develop a healthcare-associated infection (HAI). Effective infection prevention and control can avoid 1 in 3 HAIs. This means less need for antibiotics, which in turn reduces the spread of AMR. The International Health Regulations (IHR) position effective infection prevention and control as a key strategy to address public health threats of international concern, such as AMR.
The European Commission’s ‘One Health Action Plan on Antimicrobial Resistance’ is currently being discussed with the European Parliament. On 6 June, policymakers, academics, clinicians, public health organisations and industry came together to discuss sustainable solutions to the AMR crisis with an emphasis on the need to control infections in a healthcare setting.
The event, organised by 3M, produced a strong consensus that urgent and holistic action is needed to tackle AMR. “HAIs represent another piece of the puzzle of the complex topic of AMR,” said Fredrick Federley MEP, host of the event. Karin Kandenbach MEP, who is leading the Parliament’s work on the issue said: “Transformation is needed – the challenges need to be rooted in political agendas at all levels followed with bold choices and decisive actions.”
“The issue of AMR is at the top of the EC’s political agenda. The One Health Action Plan reflects the need for linking health policies and health systems with research” said Jean Eric Paquet, Director General at the European Commission’s DG-RTD. The recent EU-funded i-4-1-Health Interreg cross-border research project that combines antimicrobial stewardship and active infection prevention was highlighted by Prof Herman Goossens, University Hospital Antwerp.
“EU-JAMRAI strengthens coordination efforts directed at AMR and HAI issues following a One Health Approach. We need to keep it simple and use existing infection prevention guidelines who urgently need to be implemented in hospitals” said Olle Aspevall from EU-JAMRAI
Dominique Gilsoul, 3M Europe, said uptake of innovation was vital. “Several medtech solutions have been proved to be cost-effective and are recommended in infection prevention guidelines. EU policy should urgently incentivize hospitals to adopt these proven effective medical technologies.”
The event helped to shape EU policy, ensuring that medtech remained part of the conversation on solutions to tackle AMR. One week after the meeting, the European Parliament unanimously accepted an AMR Action Plan with key amendments on the importance of HAI Prevention and the role of medical technologies in this critical area.